SABBY MANAGEMENT, LLC - Q3 2021 holdings

$740 Million is the total value of SABBY MANAGEMENT, LLC's 184 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 42.9% .

 Value Shares↓ Weighting
COCP SellCOCRYSTAL PHARMA INC$5,424,000
-29.0%
5,165,416
-15.5%
0.73%
-31.9%
SellATOSSA THERAPEUTICS INCput$5,126,000
-68.1%
15,725
-38.2%
0.69%
-69.4%
VINC SellVINCERX PHARMA INC$3,234,000
-8.2%
200,000
-26.2%
0.44%
-11.9%
SellKEMPHARM INCput$2,717,000
-70.2%
2,912
-59.1%
0.37%
-71.5%
SellMOGO INCput$2,379,000
-63.0%
5,506
-32.7%
0.32%
-64.5%
SellORAMED PHARMACEUTICALS INCput$2,136,000
+12.6%
972
-31.5%
0.29%
+8.2%
AUTL SellAUTOLUS THERAPEUTICS LTDads$1,965,000
-26.0%
300,000
-25.0%
0.27%
-28.9%
MOGO SellMOGO INC$1,780,000
-50.7%
412,059
-10.5%
0.24%
-52.7%
PCVX SellVAXCYTE INC$1,687,000
-36.5%
66,483
-43.7%
0.23%
-39.0%
GLBS SellGLOBUS MARITIME LTD$1,626,000
-40.2%
556,883
-20.5%
0.22%
-42.6%
WIMI SellWIMI HOLOGRAM CLOUD INCads$1,581,000
-54.0%
383,791
-38.7%
0.21%
-55.9%
SellSPI ENERGY CO LTDput$1,571,000
-96.1%
3,130
-15.7%
0.21%
-96.3%
SellDIGITAL ALLY INCput$1,561,000
-47.8%
12,899
-22.4%
0.21%
-50.0%
KRBP SellKIROMIC BIOPHARMA INC$1,468,000
-39.0%
478,122
-4.5%
0.20%
-41.6%
SellATERIAN INCput$1,404,000
-49.9%
1,296
-32.3%
0.19%
-51.9%
SellTRILLIUM THERAPEUTICS INC$1,229,000
-11.7%
70,000
-51.2%
0.17%
-15.3%
ASLN SellASLAN PHARMACEUTICALS LTDads$1,225,000
-51.5%
688,400
-10.0%
0.17%
-53.4%
NUZE SellNUZEE INC$1,098,000
-47.2%
499,047
-24.4%
0.15%
-49.5%
SellCBAK ENERGY TECH INCput$920,000
-82.4%
3,521
-68.2%
0.12%
-83.2%
MRTX SellMIRATI THERAPEUTICS INC$885,000
-8.7%
5,000
-16.7%
0.12%
-12.4%
SellNEMAURA MEDICAL INCput$792,000
-61.8%
1,318
-34.3%
0.11%
-63.5%
SellCALADRIUS BIOSCIENCES INCput$776,000
-53.7%
6,362
-38.9%
0.10%
-55.5%
AMRN SellAMARIN CORP PLCadr$759,000
-47.0%
148,771
-54.5%
0.10%
-49.0%
SellOCEAN POWER TECHSput$703,000
-53.0%
3,029
-27.5%
0.10%
-55.0%
LEXXW SellLEXARIA BIOSCIENCE CORP.*w$699,000
-30.6%
332,971
-17.0%
0.09%
-33.8%
DXR SellDAXOR CORP$677,000
-34.5%
57,924
-40.6%
0.09%
-37.0%
SellARCADIA BIOSCIENCES INCput$684,000
-72.4%
3,304
-60.4%
0.09%
-73.6%
ENOB SellENOCHIAN BIOSCIENCES INC$534,000
-92.0%
79,314
-94.1%
0.07%
-92.3%
KMPH SellKEMPHARM INC$387,000
-82.5%
41,531
-75.9%
0.05%
-83.3%
SellGLOBUS MARITIME LTDput$368,000
-32.2%
1,259
-10.0%
0.05%
-35.1%
SellADITXT INCput$361,000
-74.3%
2,135
-60.6%
0.05%
-75.3%
PRFX SellPAINREFORM LTD$326,000
-66.7%
117,528
-66.2%
0.04%
-68.1%
SBEVWS SellSPLASH BEVERAGE GROUP INC*w$321,000
-66.1%
605,659
-29.6%
0.04%
-67.9%
SellTHE9 LTDcall$297,000
-50.7%
288
-31.8%
0.04%
-52.9%
SellPHIO PHARMACEUTICALS CORPput$281,000
-23.2%
1,383
-14.7%
0.04%
-26.9%
INFI SellINFINITY PHARMACEUTICALS$241,000
-81.7%
70,431
-84.0%
0.03%
-82.3%
ADOM SellADOMANI INC$232,000
-87.3%
850,000
-86.2%
0.03%
-87.9%
SellTRILLIUM THERAPEUTICS INCcall$211,000
+80.3%
120
-0.8%
0.03%
+81.2%
ADTX SellADITXT INC$208,000
-56.7%
122,863
-33.7%
0.03%
-58.8%
ATHX SellATHERSYS INC NEW$155,000
-68.8%
116,444
-66.3%
0.02%
-70.0%
SellREWALK ROBOTICS LTDput$127,000
-81.2%
839
-79.0%
0.02%
-82.1%
SellDIGINEX LTDput$119,000
-62.8%
367
-24.8%
0.02%
-64.4%
SellNABRIVA THERAPEUTICS PLCput$94,000
-43.0%
790
-35.5%
0.01%
-43.5%
HCDIW SellHARBOR CUSTOM DEVELOPMENT INC*w$83,000
-51.5%
148,975
-45.3%
0.01%
-54.2%
PHIO SellPHIO PHARMACEUTICALS CORP$83,000
-29.1%
40,684
-21.4%
0.01%
-31.2%
SellPURPLE BIOTECH LTDput$57,000
-94.3%
125
-93.9%
0.01%
-94.4%
SellEVOFEM BIOSCIENCES INCVput$54,000
-49.5%
725
-23.3%
0.01%
-53.3%
CBAT SellCBAK ENERGY TECH INC$41,000
-95.0%
17,548
-90.0%
0.01%
-94.8%
SellNABRIVA THERAPEUTICS PLC$44,000
-43.6%
36,735
-36.4%
0.01%
-45.5%
SellTITAN PHARMACEUTICALS INCput$34,000
-89.7%
184
-85.6%
0.01%
-89.4%
SellTANZANIAN GOLD CORPput$20,000
-75.0%
404
-74.2%
0.00%
-72.7%
SellIT TECH PACKAGINGput$17,000
-70.7%
254
-79.3%
0.00%
-75.0%
ODT ExitODONATE THERAPEUTICS INC$0-14,979
-100.0%
-0.01%
TCDA ExitTRICIDA INCcall$0-146
-100.0%
-0.01%
ExitADAMIS PHARMACEUTICALS CORPcall$0-553
-100.0%
-0.01%
ExitAETERNA ZENTARIS INCput$0-920
-100.0%
-0.01%
LIXTW ExitLIXTE BIOTECHNOLOGY INC*w$0-140,089
-100.0%
-0.02%
ExitVASCULAR BIOGENICS LTDput$0-492
-100.0%
-0.02%
ExitREDHILL BIOPHARMA LTDcall$0-170
-100.0%
-0.02%
ExitMETA MATERIALS INCput$0-182
-100.0%
-0.02%
TVTX ExitTRAVERE THERAPEUTICS INC$0-10,042
-100.0%
-0.02%
ExitHEPION PHARMS INCput$0-980
-100.0%
-0.03%
LIXT ExitLIXTE BIOTECHNOLOGY INC$0-65,511
-100.0%
-0.03%
AEZS ExitAETERNA ZENTARIS INC$0-244,240
-100.0%
-0.03%
ExitHEPION PHARMS INCcall$0-1,110
-100.0%
-0.03%
ExitMACROGENICS INCcall$0-92
-100.0%
-0.04%
PPBT ExitPURPLE BIOTECH LTDads$0-50,590
-100.0%
-0.04%
SLRX ExitSALARIUS PHARMACEUTICALS$0-249,033
-100.0%
-0.04%
BIOC ExitBIOCEPT INC$0-76,892
-100.0%
-0.04%
GOEDWS Exit1847 GOEDEKER INC*w$0-180,000
-100.0%
-0.05%
JOB ExitGEE GROUP INC$0-700,000
-100.0%
-0.06%
ExitMACROGENICS INCput$0-182
-100.0%
-0.07%
ExitBIOCEPT INCput$0-1,160
-100.0%
-0.07%
CLRB ExitCELLECTAR BIOSCIENCES$0-426,561
-100.0%
-0.07%
ExitADAMIS PHARMACEUTICALS CORPput$0-5,168
-100.0%
-0.08%
ExitAPPLIED GENETIC TECHNOLOGIESput$0-1,545
-100.0%
-0.08%
METX ExitMETEN EDTECHX EDUCATION LTDord$0-733,840
-100.0%
-0.10%
SHIP ExitSEANERGY MARITIME HLDGS CORP$0-650,000
-100.0%
-0.10%
TXMD ExitTHERAPEUTICSMD INC$0-625,000
-100.0%
-0.10%
BCTX ExitBRIACELL THERAPEUTICS$0-196,033
-100.0%
-0.15%
CVM ExitCEL-SCI CORP$0-145,285
-100.0%
-0.18%
BIIB ExitBIOGEN INC$0-4,000
-100.0%
-0.20%
ExitCEL-SCI CORPput$0-1,916
-100.0%
-0.23%
ExitASENSUS SURGICAL INCput$0-5,594
-100.0%
-0.25%
CBLI ExitCLEVELAND BIOLABS INC$0-400,080
-100.0%
-0.31%
ExitKEMPHARM INCcall$0-1,735
-100.0%
-0.31%
ExitBIT BROTHER LTD$0-1,039,458
-100.0%
-0.32%
RDHL ExitREDHILL BIOPHARMA LTDads$0-340,440
-100.0%
-0.33%
ASXC ExitASENSUS SURGICAL INC$0-931,414
-100.0%
-0.42%
ATER ExitATERIAN INC.$0-433,000
-100.0%
-0.89%
ATOS ExitATOSSA THERAPEUTICS INC$0-1,045,987
-100.0%
-0.93%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings